These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

128 related items for PubMed ID: 7939508

  • 21. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L, Borowiec JW, Thelin S, Hultman J.
    Scand Cardiovasc J; 1997; 31(5):275-81. PubMed ID: 9406294
    [Abstract] [Full Text] [Related]

  • 22. Reduced complement and granulocyte activation with heparin-coated cardiopulmonary bypass.
    Fosse E, Moen O, Johnson E, Semb G, Brockmeier V, Mollnes TE, Fagerhol MK, Venge P.
    Ann Thorac Surg; 1994 Aug; 58(2):472-7. PubMed ID: 8067851
    [Abstract] [Full Text] [Related]

  • 23. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass.
    Steinberg BM, Grossi EA, Schwartz DS, McLoughlin DE, Aguinaga M, Bizekis C, Greenwald J, Flisser A, Spencer FC, Galloway AC.
    Ann Thorac Surg; 1995 Sep; 60(3):525-9. PubMed ID: 7677475
    [Abstract] [Full Text] [Related]

  • 24. Haemostasis at low heparin dosage during cardiopulmonary bypass with heparin-coated circuits in pigs.
    Bagge L, Borowiec JW, Thelin S, Hultman J.
    Scand Cardiovasc J; 1997 Sep; 31(6):275-81. PubMed ID: 9498931
    [Abstract] [Full Text] [Related]

  • 25. Heparin-coated circuits reduce activation of granulocytes during cardiopulmonary bypass. A clinical study.
    Borowiec J, Thelin S, Bagge L, Nilsson L, Venge P, Hansson HE.
    J Thorac Cardiovasc Surg; 1992 Sep; 104(3):642-7. PubMed ID: 1325013
    [Abstract] [Full Text] [Related]

  • 26. Biocompatibility of heparin-coated circuits in pediatric cardiopulmonary bypass.
    Kagisaki K, Masai T, Kadoba K, Sawa Y, Nomura F, Fukushima N, Ichikawa H, Ohata T, Suzuki K, Taketani S, Matsuda H.
    Artif Organs; 1997 Jul; 21(7):836-40. PubMed ID: 9212969
    [Abstract] [Full Text] [Related]

  • 27. Circulating cytokines and granulocyte-derived enzymes during complex heart surgery. A clinical study with special reference to heparin-coating of cardiopulmonary bypass circuits.
    Borowiec JW, Hagman L, Tötterman TH, Pekna M, Venge P, Thelin S.
    Scand J Thorac Cardiovasc Surg; 1995 Jul; 29(4):167-74. PubMed ID: 8789469
    [Abstract] [Full Text] [Related]

  • 28. Increased cerebral blood flow velocities assessed by transcranial Doppler examination is associated with complement activation after cardiopulmonary bypass.
    Baufreton C, Pinaud F, Corbeau JJ, Chevailler A, Jolivot D, Ter Minassian A, Henrion D, de Brux JL.
    Perfusion; 2011 Mar; 26(2):91-8. PubMed ID: 21173036
    [Abstract] [Full Text] [Related]

  • 29. Comparison of three oxygenator-coated and one total-circuit-coated extracorporeal devices.
    Baksaas ST, Videm V, Pedersen T, Karlsen H, Mollnes TE, Brosstad F, Svennevig JL.
    Perfusion; 1999 Mar; 14(2):119-27. PubMed ID: 10338323
    [Abstract] [Full Text] [Related]

  • 30. Safe use of heparin-coated bypass circuits incorporating a pump-oxygenator.
    Jones DR, Hill RC, Vasilakis A, Hollingsed MJ, Graeber GM, Gustafson RA, Cruzzavala JL, Murray GF.
    Ann Thorac Surg; 1994 Apr; 57(4):815-8; discussion 818-9. PubMed ID: 8166524
    [Abstract] [Full Text] [Related]

  • 31. Heparin-coated cardiopulmonary bypass circuits reduce circulating complement factors and interleukin-6 in paediatric heart surgery.
    Olsson C, Siegbahn A, Henze A, Nilsson B, Venge P, Joachimsson PO, Thelin S.
    Scand Cardiovasc J; 2000 Apr; 34(1):33-40. PubMed ID: 10816058
    [Abstract] [Full Text] [Related]

  • 32.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 33. Biocompatibility of three different membrane oxygenators: effects on complement, neutrophil and monocyte activation.
    de Vroege R, Rutten PM, Kalkman C, Out TA, Jansen PG, Eijsman L, de Mol BJ, Wildevuur CR.
    Perfusion; 1997 Nov; 12(6):369-75. PubMed ID: 9413849
    [Abstract] [Full Text] [Related]

  • 34. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits.
    Ovrum E, Mollnes TE, Fosse E, Holen EA, Tangen G, Abdelnoor M, Ringdal MA, Oystese R, Venge P.
    J Thorac Cardiovasc Surg; 1995 Dec; 110(6):1623-32. PubMed ID: 8523872
    [Abstract] [Full Text] [Related]

  • 35. Biocompatibility of heparin-coated cardiopulmonary bypass circuits in coronary patients with left ventricular dysfunction is superior to PMEA-coated circuits.
    Kutay V, Noyan T, Ozcan S, Melek Y, Ekim H, Yakut C.
    J Card Surg; 2006 Dec; 21(6):572-7. PubMed ID: 17073955
    [Abstract] [Full Text] [Related]

  • 36. Centrifugal pump and heparin coating improves cardiopulmonary bypass biocompatibility.
    Moen O, Fosse E, Dregelid E, Brockmeier V, Andersson C, Høgåsen K, Venge P, Mollnes TE, Kierulf P.
    Ann Thorac Surg; 1996 Oct; 62(4):1134-40. PubMed ID: 8823102
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39. Clinical and biomaterial evaluation of hyaluronan-based heparin-bonded extracorporeal circuits with reduced versus full systemic anticoagulation in reoperation for coronary revascularization.
    Gunaydin S, Farsak B, McCusker K, Vijay V, Sari T, Onur MA, Gurpinar A, Zorlutuna Y.
    J Cardiovasc Med (Hagerstown); 2009 Feb; 10(2):135-42. PubMed ID: 19377380
    [Abstract] [Full Text] [Related]

  • 40. Cardiopulmonary bypass circuit treated with surface-modifying additives: a clinical evaluation of blood compatibility.
    Gu YJ, Boonstra PW, Rijnsburger AA, Haan J, van Oeveren W.
    Ann Thorac Surg; 1998 May; 65(5):1342-7. PubMed ID: 9594864
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 7.